Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2003
This study will evaluate whether the HIV vaccine ALVAC vCP1452 given in combination with interleukin-2 (IL-2), also known as aldesleukin, can increase immune system function in people with HIV infection.
Epistemonikos ID: 2712fc4c98e879f869c694cf1c08f3e2fba1080b
First added on: Dec 01, 2021